Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADD study of peginterferon alfa-2b add-on after nucleos(t)ide analogue pretreatment in HBeAg-positive chronic hepatitis B
NL-OMON35145Phase 3Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- May 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of peginterferon alfa-2b, sponsored by Erasmus MC. Started May 2009; status: active, not recruiting.
02
Drugs
peginterferon alfa-2b
Beyond the preview
Go deeper on NL-OMON35145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35145.